SCHEMBL20273750

SCHEMBL20273750

CNc1nc(-c2cccnc2)nc2ccc(-c3cccc(N)c3)cc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.64
▸ CYP3A4 P08684 4/20 0.64
▸ CLK4 Q9HAZ1 2/20 0.64
▸ CYP2C19 P33261 2/20 0.64
▸ HSD17B10 Q99714 2/20 0.64
▸ CYP2D6 P10635 1/20 0.64
▸ CYP2C9 P11712 1/20 0.64
▸ ABCG2 Q9UNQ0 5/20 0.59
▸ MEN1 O00255 1/20 0.52
▸ PSIP1 O75475 1/20 0.52
▸ AXL P30530 1/20 0.52
▸ MKNK1 Q9BUB5 1/20 0.52
▸ MKNK2 Q9HBH9 1/20 0.52
▸ PDE5A O76074 6/20 0.50
▸ TSHR P16473 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ USP2 O75604 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ ABCB1 P08183 1/20 0.48
▸ MAPK1 P28482 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20273785 0.92 CYP1A2 (0.65) CYP1A2CYP3A4CLK4CYP2C19HSD17B10
SCHEMBL14475618 0.90 CYP1A2 (0.70) CYP1A2CYP3A4CLK4CYP2C19HSD17B10
SCHEMBL14475902 0.90 CYP1A2 (0.73) CYP1A2CYP3A4CLK4CYP2C19HSD17B10
SCHEMBL14475161 0.89 CYP1A2 (0.72) CYP1A2CYP3A4CLK4CYP2C19HSD17B10
SCHEMBL14475073 0.89 CYP1A2 (0.76) CYP1A2CYP3A4CLK4CYP2C19HSD17B10
SCHEMBL14475835 0.89 CYP1A2 (0.76) CYP1A2CYP3A4CLK4CYP2C19HSD17B10
SCHEMBL14727977 0.87 CYP1A2 (0.65) CYP1A2CYP3A4CLK4CYP2C19HSD17B10
SCHEMBL14475852 0.87 CYP1A2 (0.65) CYP1A2CYP3A4CLK4CYP2C19HSD17B10
SCHEMBL14475877 0.86 CLK4 (0.64) CYP1A2CYP3A4CLK4CYP2C19HSD17B10
SCHEMBL2154673 0.86 CYP1A2 (0.64) CYP1A2CYP3A4CLK4CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3056207-B1 THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE OTSUKA PHARMA CO LTD (JP) 2018-06-20 — — EP disclosed
Send feedback